Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem Cell TransplantationHematopoietic Stem CellsBone and BonesTransplantation ConditioningLeukemiaAnemia, AplasticGraft SurvivalTissue DonorsTransplantation ChimeraKidney TransplantationLiver TransplantationBusulfanHistocompatibility TestingHematopoiesisBone Marrow PurgingHistocompatibilityGraft RejectionTransplantation, IsogeneicImmunosuppressive AgentsCyclophosphamideBone Marrow DiseasesHematologic NeoplasmsMice, Inbred C57BLRecurrenceTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteRadiation ChimeraTime FactorsHeart TransplantationCombined Modality TherapyTransplantation ImmunologyImmunosuppressionBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionLeukemia, MyeloidLung TransplantationHepatic Veno-Occlusive DiseaseColony-Forming Units AssayAcute DiseaseBone RemodelingRetrospective StudiesStem Cell TransplantationBone Marrow NeoplasmsCyclosporineLymphocyte DepletionGraft vs Host ReactionT-LymphocytesLymphoma, Non-HodgkinHLA AntigensSurvival AnalysisLeukocyte TransfusionChimeraCell DifferentiationMyelodysplastic SyndromesSevere Combined ImmunodeficiencyAntigens, CD34Hematologic DiseasesCytomegalovirus InfectionsTransplantationLymphocyte TransfusionFollow-Up StudiesActuarial AnalysisFlow CytometrySurvival RateGraft vs Tumor EffectBone DensityCells, CulturedAntineoplastic Combined Chemotherapy ProtocolsCarmustineGraft vs Leukemia EffectNuclear FamilyTransplantsSpleenGranulocyte Colony-Stimulating FactorMice, Inbred BALB CPancytopeniaLeukocyte CountDisease-Free SurvivalCytarabineOrgan TransplantationGranulocytesBlood CellsLymphomaMice, KnockoutMelphalanMultiple MyelomaCord Blood Stem Cell TransplantationHematopoietic SystemLiving DonorsPostoperative ComplicationsAntilymphocyte Serum